Home
FibroGen

FibroGen Market Share Analysis for November 2025

Dedicated to Developing New Treatment Options Safely and Responsibly At FibroGen, we are dedicated to advancing first-in-class medicines that have the potential to provide new and effective treatment options to the patients who need them

Health > Biotechnology and Pharmaceuticals

Domainfibrogen.com

Year Founded1993

Employees201 - 500

Annual Revenue$200M - $500M

FibroGen

FibroGen (including company regionals)

fibrogen.com

See more website traffic and engagement information

FibroGen Revenue up to November 2025 is 200M - 500M

revenue generated by FibroGen top domains

FibroGen top domains revenue over 3 years

Revenue for FibroGen top domains

fibrogen.com200M - 500M

See more with Sales Intelligence

Total visits to FibroGen's top domains

Understand FibroGen market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

fibrogen.com5.2K

See more with Sales Intelligence

Avg. visit duration in FibroGen's top domains

Analyze FibroGen engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

fibrogen.com00:00:32

See more with Sales Intelligence

Avg. pageviews on FibroGen's top domains

See how FibroGen keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

fibrogen.com1.81

See more with Sales Intelligence

FibroGen top competitors by domain

Top similar sites in November 2025, ranked by their affinity

cellarity.comCompany NameCellarity, Inc.Employees51 - 200HQUnited States, Massachusetts, SomervilleAnnual revenue$5M - $10MTotal visits5.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by FibroGen

These are the website technologies, by industry, used by FibroGen top domains

Advertising (3)

PubMatic

Content Management System (3)

WordPress

Payment & Currencies (3)

Cart Functionality

Widget (3)

Twemoji

More Technologies

8

See all

News & Signals from FibroGen

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsFibroGen, Inc. attended event Oppenheimer Movers in Rare Disease Summit on Dec 11th '25.SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) - FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the Oppenheimer Movers in Rare Disease Summit being held on December 11, 2025, in New York, NY.

NewsFibroGen, Inc. has issues with charging securities fraud under Section 17.On September 5, 2025, the SEC brought a settled administrative proceeding against FibroGen, charging securities fraud under Section 17(a)(2) of the Securities Act of 1933, Section 10(b) of the Securities Exchange Act of 1934, and Rule 10b-5(b).